Discussing Customer and Patient Outcomes at the AACC 2018

At the 70^th AACC Annual Scientific Meeting and Clinical Lab Expo, Siemens Healthineers is presenting innovations which help transform care delivery in order to achieve better clinical and business outcomes. Representatives on-site showcase offerings from laboratory automation, over point-of-care in emergency departments, to molecular testing.

Klinikum Frankfurt Höchst, Germany, found a way to save time, reduce costs, minimize errors, and streamline regulatory compliance in its laboratory inventory management processes.

Worldwide, the prevalence of chronic kidney disease has increased dramatically. The cost of treating this growing epidemic represents a tremendous burden on patients, families, and healthcare systems. Solutions that improve prevention and early detection must be a priority.

Markus Tiemann, MD, is the Chief Executive Officer and founder of the Institute for Hematopathology in Hamburg, Germany. During the 2017 American Society of Clinical Oncology meeting in Chicago, he discussed molecular pathology, clinical decision-making in oncology, and his recent collaboration with the Siemens Healthineers daughter NEO New Oncology in the field of molecular tumor diagnostics.

Thanks to high-sensitivity troponin I assays, new possibilities have emerged for quicker, more accurate diagnoses of myocardial infarction. Peter Kavsak, PhD, talks about their potential to significantly impact patient care and protocols.